Restatement of Previously Issued Financial Statements (Details) - Schedule of condensed statement of operations - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2020
As Previously Reported [Member]
Condensed Income Statements, Captions [Line Items]
Loss from operations	$ (160,421)	$ (176,156)
Change in fair value of derivative warrant liabilities
Financing costs
Gain on investments Held in Trust Accounts	3,736	3,736
Total other (expense) income	3,736	3,736
Net loss	$ (156,685)	$ (172,420)
Basic and Diluted weighted-average Class B ordinary shares outstanding (in Shares)	2,926,250	2,713,182
Basic and Diluted net loss per Class B share (in Dollars per share)	$ (0.05)	$ (0.06)
Restatement Adjustment [Member]
Condensed Income Statements, Captions [Line Items]
Loss from operations
Change in fair value of derivative warrant liabilities	184,000	184,000
Financing costs	(314,650)	(314,650)
Gain on investments Held in Trust Accounts
Total other (expense) income	(130,650)	(130,650)
Net loss	$ (130,650)	$ (130,650)
Basic and Diluted weighted-average Class B ordinary shares outstanding (in Shares)
As Restated [Member]
Condensed Income Statements, Captions [Line Items]
Loss from operations	$ (160,421)	$ (176,156)
Change in fair value of derivative warrant liabilities	184,000	184,000
Financing costs	(314,650)	(314,650)
Gain on investments Held in Trust Accounts	3,736	3,736
Total other (expense) income	(126,914)	(126,914)
Net loss	$ (287,335)	$ (303,070)
Basic and Diluted weighted-average Class B ordinary shares outstanding (in Shares)	2,926,250	2,713,182
Basic and Diluted net loss per Class B share (in Dollars per share)	$ (0.10)	$ (0.11)